Literature DB >> 20195928

Overcoming the effect of rifampin on the tacrolimus metabolism by itraconazole administration in an allogeneic hematopoietic stem cell transplant recipient.

Takehiko Mori, Yoshinobu Aisa, Jun Kato, Yukinori Nakamura, Takayuki Shimizu, Shinichiro Okamoto.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20195928     DOI: 10.1007/s12185-010-0535-7

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  13 in total

1.  Pharmacokinetic evaluation of the drug interaction between intravenous itraconazole and intravenous tacrolimus or intravenous cyclosporin A in allogeneic hematopoietic stem cell transplant recipients.

Authors:  Helen Leather; Renee M Boyette; Lili Tian; John R Wingard
Journal:  Biol Blood Marrow Transplant       Date:  2006-03       Impact factor: 5.742

Review 2.  Factors influencing the magnitude and clinical significance of drug interactions between azole antifungals and select immunosuppressants.

Authors:  Aline H Saad; Daryl D DePestel; Peggy L Carver
Journal:  Pharmacotherapy       Date:  2006-12       Impact factor: 4.705

3.  Acute rejection and massive cyclosporine requirements in heart transplant recipients treated with rifampin.

Authors:  D L Modry; E B Stinson; P E Oyer; S W Jamieson; J C Baldwin; N E Shumway
Journal:  Transplantation       Date:  1985-03       Impact factor: 4.939

Review 4.  Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA.

Authors:  J M Aguado; J A Herrero; J Gavaldá; J Torre-Cisneros; M Blanes; G Rufí; A Moreno; M Gurguí; M Hayek; C Lumbreras; C Cantarell
Journal:  Transplantation       Date:  1997-05-15       Impact factor: 4.939

5.  Renal allograft dysfunction associated with rifampin-tacrolimus interaction.

Authors:  R Y Chenhsu; C C Loong; M H Chou; M F Lin; W C Yang
Journal:  Ann Pharmacother       Date:  2000-01       Impact factor: 3.154

6.  Comparative effects of rifabutin and rifampicin on cytochromes P450 and UDP-glucuronosyl-transferases expression in fresh and cryopreserved human hepatocytes.

Authors:  B Reinach; G de Sousa; P Dostert; R Ings; J Gugenheim; R Rahmani
Journal:  Chem Biol Interact       Date:  1999-06-01       Impact factor: 5.192

7.  The prophylactic effect of itraconazole capsules and fluconazole capsules for systemic fungal infections in patients with acute myeloid leukemia and myelodysplastic syndromes: a Japanese multicenter randomized, controlled study.

Authors:  Yoshikazu Ito; Kazuma Ohyashiki; Isao Yoshida; Makoto Takeuchi; Yasutaka Aoyama; Atsuko Mugitani; Yasuhiro Matsuura; Hisashi Wakita; Mitsuhiro Matsuda; Erina Sakamoto; Toru Kiguchi; Akio Urabe; Kazuo Tamura; Akihisa Kanamaru; Toru Masaoka
Journal:  Int J Hematol       Date:  2007-02       Impact factor: 2.490

Review 8.  Update on rifampin and rifabutin drug interactions.

Authors:  Anne M Baciewicz; Cary R Chrisman; Christopher K Finch; Timothy H Self
Journal:  Am J Med Sci       Date:  2008-02       Impact factor: 2.378

9.  Low cyclosporin A blood levels and acute graft rejection in a renal transplant recipient during rifampin treatment.

Authors:  G Offermann; F Keller; M Molzahn
Journal:  Am J Nephrol       Date:  1985       Impact factor: 3.754

10.  Severe reduction in tacrolimus levels with rifampin despite multiple cytochrome P450 inhibitors: a case report.

Authors:  S Bhaloo; G V R Prasad
Journal:  Transplant Proc       Date:  2003-11       Impact factor: 1.066

View more
  1 in total

1.  Decreased tacrolimus levels after administration of rifampin to a patient with renal transplant.

Authors:  Heather Naylor; Jenna Robichaud
Journal:  Can J Hosp Pharm       Date:  2013-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.